Siena Biotech has acquired a minority stake in Aptuit’s operations in Verona, Italy. In return, Aptuit will become the provider of choice for Siena’s development pipeline of compounds, focused in three key therapeutic areas, including Alzheimer’s disease, Huntington’s disease and oncology.
Mass High Tech
Monday 2 August 2010
Aptuit partners with Siena
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment